Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Florian Kretz, WOC 2018 – Latest Advances in IOL Technology

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 26th 2018

In the last few years, we have seen many developments in intraocular lenses (IOLs). Dr Florian Kretz, Consultant at the Department of Ophthalmology, University Hospital Heidelberg, discusses how toric IOLs can benefit patients with astigmatism. He also reviews the future of cataract surgery, including the use of femtosecond laser and how the union between diagnostic tools and surgical procedures has enhanced surgical outcome.

Questions:

1. What have been the most significant recent developments in the area of IOLs? (0:26)
2. What challenges do you face when treating patients with cataracts? (1:05)
3. What does the future look like for cataract surgery? (1:45)

Filmed at the 2018 World Ophthalmology Congress (WOC) of the International Council of Ophthalmology (ICOPH), June 2018, Barcelona, Spain.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup